ZBH — ZIMMER BIOMET HOLDINGS, INC.

NYSE · Health Care · Health Care Equipment & Supplies · CIK 1136869 ·
Last close
$89.63
Market Cap
$17.34B
52W High
$97.81
52W Low
$79.12
ADV30
2,618,223
Next earnings
2026-04-28
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 2,086,700,000 1,510,500,000 395,100,000 238,100,000 22,721,600,000 424,200,000 10,040,000,000
Dec 2025 2,243,700,000 1,451,300,000 282,600,000 139,300,000 23,091,700,000 591,900,000 10,385,900,000
Sep 2025 2,001,400,000 1,442,100,000 338,300,000 230,900,000 23,488,000,000 1,292,700,000 10,722,000,000
Jun 2025 2,077,300,000 1,485,100,000 396,400,000 152,800,000 22,865,100,000 556,900,000 10,330,800,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$1,673,700,000
Investing CF
$-2,028,700,000
Financing CF
$-618,600,000
CapEx
$-305,200,000
Dividends Paid
$-189,400,000
Buybacks
$-507,300,000
EPS Diluted TTM
$4.06
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$11,802,500,000
Inventory
$2,246,800,000
Receivables
$1,728,600,000
ST Investments
EBIT TTM
$1,198,500,000
Pretax Income TTM
$903,100,000
Interest Exp TTM
$295,400,000
Analysts
21

Yahoo Snapshot (yfinance, live)

Total Revenue
$8,409,099,776
EBITDA
$2,580,999,936
Free Cash Flow
$1,044,124,992
Enterprise Value
$24,456,742,912
Total Cash
$478,500,000
Total Debt
$7,586,999,808
Shares Out
193,462,482
Trailing EPS
$3.86
Book Value
$65.53
ROE
6.1%
ROA
4.1%
Div Yield
1.07%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 8,231,500,000 1,356,200,000 705,100,000 23,091,700,000 10,385,900,000 1,697,100,000
Dec 2024 7,678,600,000 1,528,300,000 903,800,000 21,365,300,000 8,889,100,000 1,499,400,000
Dec 2023 7,394,200,000 1,451,300,000 1,024,000,000 21,496,900,000 9,008,800,000 1,581,600,000
Dec 2022 6,939,900,000 1,192,100,000 231,400,000 21,066,000,000 9,039,000,000 1,284,700,000

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$9.00

Max Pain — expiry 2026-06-18

max pain strike: $85.00 · spot: $89.63 · call oi: 2,317 · put oi: 1,685
Expected Move to 2026-06-18: ±$3.68 (4.11%) — implied range $85.95$93.31 · ATM straddle on $90.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
STE STERIS plc $20.78B $212.88
SOLV Solventum Corp $14.28B $82.46
SNN SMITH & NEPHEW PLC $13.29B $31.32
SNNUF SMITH & NEPHEW PLC $12.82B $15.10
ALGN ALIGN TECHNOLOGY INC $12.76B $178.10

News headlines (Yahoo Finance, 1h cache)

Is Zimmer Biomet Holdings, Inc. (ZBH) A Good Stock To Buy Now?
2026-06-09 14:30 · Yahoo
Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?
2026-06-09 14:07 · Yahoo
Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom
2026-06-09 14:01 · Yahoo
Why Is Perrigo (PRGO) Down 9% Since Last Earnings Report?
2026-06-05 15:30 · Yahoo
Here's How Financial Strength Remains a Key Advantage for GMED
2026-06-04 15:55 · Yahoo
Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?
2026-06-02 14:29 · Yahoo
Zimmer Biomet to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
2026-06-02 11:30 · Yahoo
2 Profitable Stocks to Consider Right Now and 1 We Question
2026-06-02 09:57 · Yahoo
GE HealthCare (GEHC) Up 3.3% Since Last Earnings Report: Can It Continue?
2026-05-29 15:30 · Yahoo
Zimmer (ZBH) Up 3.1% Since Last Earnings Report: Can It Continue?
2026-05-28 15:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.